Publicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (7)

2024

  1. Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial

    Journal of the American Society of Nephrology, Vol. 35, Núm. 5, pp. 594-606

2023

  1. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

  2. Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

    Current Medical Research and Opinion, Vol. 39, Núm. 10, pp. 1395-1405

2022

  1. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain

    Chest, Vol. 162, Núm. 5, pp. 1017-1029

2021

  1. Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)

    BMC Pulmonary Medicine, Vol. 21, Núm. 1

2019

  1. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2013

  1. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

    New England Journal of Medicine, Vol. 369, Núm. 14, pp. 1317-1326